In Vitro Evaluation of Double and Triple Combinations of Antifungal Drugs against Aspergillus fumigatus and Aspergillus terreus
Open Access
- 1 March 2004
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 48 (3) , 970-978
- https://doi.org/10.1128/aac.48.3.970-978.2004
Abstract
Microdilution broth checkerboard techniques based on the National Committee for Clinical Laboratory Standards methodology were used to study double and triple antifungal combinations against clinical isolates of Aspergillus fumigatus and A. terreus . The influences of the end-point definition (partial or complete inhibition) and the mode of reading (visually or spectrophotometrically) were determined. Interactions between antifungal drugs were also evaluated by agar diffusion tests. Combinations of caspofungin with either amphotericin B or voriconazole were additive for all the isolates, and antagonism was not observed. The interaction between caspofungin and flucytosine was synergistic for 62% of the isolates. In contrast, the interaction between voriconazole and flucytosine was never synergistic and antagonism was noted for 93% of the isolates. The triple combination of caspofungin with flucytosine and amphotericin B was synergistic for all the isolates tested. The triple combination of caspofungin with flucytosine and voriconazole was also mostly synergistic; but complex interactions were obtained for some isolates, with synergy or antagonism depending on the concentrations of caspofungin and voriconazole. Analysis of the influence of the reading technique on the results showed that spectrophotometric reading was a good alternative to the recommended visual reading. The results of these in vitro tests suggest that the activity of flucytosine as part of a double combination with caspofungin and as part of a triple combination with caspofungin and amphotericin B against Aspergillus spp. warrants further investigations. Animal studies are needed to evaluate the in vivo efficacies of these combinations.Keywords
This publication has 46 references indexed in Scilit:
- In Vitro Interaction of Flucytosine with Conventional and New Antifungals against Cryptococcus neoformans Clinical IsolatesAntimicrobial Agents and Chemotherapy, 2003
- Influences of Methodological Variables on Susceptibility Testing of Caspofungin against Candida Species and Aspergillus fumigatusAntimicrobial Agents and Chemotherapy, 2003
- Combination Therapy in Treatment of Experimental Pulmonary Aspergillosis: Synergistic Interaction between an Antifungal Triazole and an EchinocandinThe Journal of Infectious Diseases, 2003
- In Vitro Synergy of Caspofungin and Itraconazole against Aspergillus spp.: MIC versus Minimal Effective Concentration End PointsAntimicrobial Agents and Chemotherapy, 2003
- In Vitro Drug Interaction Modeling of Combinations of Azoles with Terbinafine against ClinicalScedosporium prolificansIsolatesAntimicrobial Agents and Chemotherapy, 2003
- Efficacy of Caspofungin Alone and in Combination with Voriconazole in a Guinea Pig Model of Invasive AspergillosisAntimicrobial Agents and Chemotherapy, 2002
- Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive AspergillosisClinical Infectious Diseases, 2002
- Aspergillosis Case-Fatality Rate: Systematic Review of the LiteratureClinical Infectious Diseases, 2001
- Practice Guidelines for the Management of Cryptococcal DiseaseClinical Infectious Diseases, 2000
- Use of spectrophotometric reading for in vitro antifungal susceptibility testing ofAspergillusspp.Canadian Journal of Microbiology, 1999